ZO

Northwest Medical Arts Becomes Gathering Place for South Sound

Retrieved on: 
Thursday, October 12, 2023
Candy, ZO, Veteran, Hope, PTAS, NWMA, PTSD, ARNP, Human, Peel (fruit), Filler (linguistics), Skin, B-12, Interior design, Sculptra

UNIVERSITY PLACE, Wash., Oct. 12, 2023 /PRNewswire/ -- Northwest Medical Arts (NWMA), Tacoma's premier comprehensive skin health & rejuvenation center, has built its reputation on giving back and creating a space where all are welcome. They are hosting a free Halloween-themed event for all ages on Sunday, October 22 from 12pm-4pm in their parking lot at 5350 Orchard Street West in University Place, Washington.

Key Points: 
  • UNIVERSITY PLACE, Wash., Oct. 12, 2023 /PRNewswire/ -- Northwest Medical Arts (NWMA) , Tacoma's premier comprehensive skin health & rejuvenation center, has built its reputation on giving back and creating a space where all are welcome.
  • Since launch, Northwest Medical Arts has hosted several community events, received dozens of 5-star reviews and donated thousands to local families and nonprofits.
  • Northwest Medical Arts also offers their beautiful location featuring modern furnishings and warm ambiance for receptions and gatherings of home-based businesses, PTAs, moms meet ups and more.
  • Ask about hosting your next event at Northwest Medical Arts or plan a special private party with group discounts on products and services.

ZEISS Presents New Surgical Workflow Innovations at ASCRS

Retrieved on: 
Tuesday, May 2, 2023
Cornea, CT, Surgeon, Refractive surgery, ATLAS, Cataract, Quality of life, Corneal topography, Gyration tensor, ASCRS, Pathology, Doctor of Philosophy, American Society of Cataract and Refractive Surgery, U.S. FDA, Gaussian beam, Intraocular lens, Capsulotomy, Patient, Ophthalmology, Architecture, ZEISS, Diagnosis, Health, Conference, FDA, Society, ZO, LVC, Dentistry, Medical device, Medical imaging, Telescopic sight, IOL

JENA, Germany and DUBLIN, Calif., May 2, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Surgery (ASCRS) annual conference from May 6-8, 2023, in San Diego, CA. These products as part of the ZEISS Medical Ecosystem help enhance ophthalmic care within the cataract and corneal refractive workflows for improved diagnosis and treatment efficiency of surgical patients:

Key Points: 
  • JENA, Germany and DUBLIN, Calif., May 2, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Surgery (ASCRS) annual conference from May 6-8, 2023, in San Diego, CA.
  • These products as part of the ZEISS Medical Ecosystem help enhance ophthalmic care within the cataract and corneal refractive workflows for improved diagnosis and treatment efficiency of surgical patients:
    The ATLAS™ 500 from ZEISS supports more efficient surgical diagnostics enhancing patient outcomes.
  • The CT LUCIA® 621P Monofocal IOL from ZEISS received U.S. FDA approval, offering a unique ZEISS Optic to treat a wide range of cataract patients.
  • ZEISS will showcase its new surgical workflow solutions during the American Society of Cataract and Refractive Surgery (ASCRS) Annual Conference from May 6-8, 2023, at booth 1437.

ZEISS Announces U.S. FDA Approval of the CT LUCIA 621P Monofocal IOL, Offering the Unique ZEISS Optic to the U.S. Market

Retrieved on: 
Tuesday, April 25, 2023
CT, Surgeon, Refractive surgery, Cataract, Eye, Gyration tensor, ASCRS, Doctor of Philosophy, American Society of Cataract and Refractive Surgery, MD, Patient, Architecture, FDA, Health, Regulation of tobacco by the U.S. Food and Drug Administration, Society, ZO, Food, Veterinary medicine, Telescopic sight, ZEISS, IOL

JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved the CT LUCIA® 621P Monofocal IOL from ZEISS, an aspheric, monofocal, single-piece C-loop IOL. The IOL features the patented ZEISS Optic (ZO) Asphericity Concept, which is designed to compensate for a wide range of spherical aberrations and at the same time optimize visual outcomes in the event of potential decentration and lens misalignments.

Key Points: 
  • JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved the CT LUCIA® 621P Monofocal IOL from ZEISS , an aspheric, monofocal, single-piece C-loop IOL.
  • The CT LUCIA 621P Monofocal IOL is a key element of the ZEISS cataract workflow solution portfolio enabling surgeons to deliver optimized visual outcomes for cataract patients.
  • The CT LUCIA® 621P Monofocal IOL from ZEISS will be showcased at the American Society of Cataract and Refractive Surgery (ASCRS) conference in San Diego, CA, from May 5-8, 2023.
  • Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development.

ZEISS Announces U.S. FDA Approval of the CT LUCIA 621P Monofocal IOL, Offering the Unique ZEISS Optic to the U.S. Market

Retrieved on: 
Tuesday, April 25, 2023
CT, Surgeon, Refractive surgery, Cataract, Eye, Gyration tensor, ASCRS, Doctor of Philosophy, American Society of Cataract and Refractive Surgery, MD, Patient, Architecture, FDA, Health, Regulation of tobacco by the U.S. Food and Drug Administration, Society, ZO, Food, Veterinary medicine, Telescopic sight, ZEISS, IOL

JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved the CT LUCIA® 621P Monofocal IOL from ZEISS, an aspheric, monofocal, single-piece C-loop IOL. The IOL features the patented ZEISS Optic (ZO) Asphericity Concept, which is designed to compensate for a wide range of spherical aberrations and at the same time optimize visual outcomes in the event of potential decentration and lens misalignments.

Key Points: 
  • JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved the CT LUCIA® 621P Monofocal IOL from ZEISS , an aspheric, monofocal, single-piece C-loop IOL.
  • The CT LUCIA 621P Monofocal IOL is a key element of the ZEISS cataract workflow solution portfolio enabling surgeons to deliver optimized visual outcomes for cataract patients.
  • The CT LUCIA® 621P Monofocal IOL from ZEISS will be showcased at the American Society of Cataract and Refractive Surgery (ASCRS) conference in San Diego, CA, from May 5-8, 2023.
  • Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development.

Tishman Speyer's The Spiral Earns CoStar's Commercial Development of Year Honors

Retrieved on: 
Friday, March 31, 2023
Debevoise & Plimpton, Line, Botany, HSBC, Wi-Fi, Food, AllianceBernstein, High Line, Llama, Certification, Tenth Avenue, Spiral, Gold, Clubhouse, LEED, Lunch, SEB, Hudson Park and Boulevard, Studio, United Kingdom, CoStar Group, Health, ZO, Turner Construction, Pfizer, Film industry, Bookbinding, Hotel, NewYork-Presbyterian Hospital

NEW YORK, March 31, 2023 /PRNewswire/ -- Tishman Speyer today announced that The Spiral, its recently-completed West Midtown office tower, has won the 2023 CoStar Impact Award for best commercial development in the New York City region.

Key Points: 
  • NEW YORK, March 31, 2023 /PRNewswire/ -- Tishman Speyer today announced that The Spiral, its recently-completed West Midtown office tower, has won the 2023 CoStar Impact Award for best commercial development in the New York City region.
  • Designed by BIG-Bjarke Ingels Group, The Spiral rises to 1,031 feet and features a cascading series of landscaped terraces and hanging gardens as its signature element.
  • "Since day one, Tishman Speyer has been focused on making The Spiral the world's most innovative, collaborative and human-centric office environment," said Tishman Speyer Senior Managing Director and Regional Director of New York Chris Shehadeh.
  • The Spiral, which is pursuing LEED Gold certification, prioritizes people first through its biophilic design and intense focus on health, wellness and sustainability.

ELEVAI LABS EXPANDS ADVISORY BOARD WITH THE ADDITION OF JAMES R. HEADLEY AS STRATEGIC ADVISOR

Retrieved on: 
Tuesday, November 29, 2022
Lazarus, Growth, Estée Lauder Companies, ZO, Biotechnology, Physician, Patient, INC, Exosome, Macy, Skin, Macy's, Inc., Management, Pharmaceutical industry

NEWPORT BEACH, Calif., Nov. 29, 2022 /PRNewswire/ -- ELEVAI LABS, INC., a medical aesthetic biotechnology company specializing in regenerative skincare, proudly announces that cosmetic industry veteran James R. Headley joins the team as a Strategic Advisor.

Key Points: 
  • NEWPORT BEACH, Calif., Nov. 29, 2022 /PRNewswire/ -- ELEVAI LABS, INC ., a medical aesthetic biotechnology company specializing in regenerative skincare, proudly announces that cosmetic industry veteran James R. Headley joins the team as a Strategic Advisor.
  • Mr. Headley, previously CEO of ZO Skin Health, will play an active role in supporting the ELEVAI management team as it evaluates strategic growth initiatives, product launches and partnerships.
  • "I am pleased to join the ELEVAI Labs Team as a Strategic Advisor," shares.
  • ELEVAI Labs develops state-of-the-art topical aesthetic and medical-grade skin care for the physician-dispensed market, with a focus on leveraging a proprietary stem cell exosome technology.

Tishman Speyer and Project Destined Launch First Global Partnership to Introduce Students from Underserved Communities to Careers in Real Estate

Retrieved on: 
Tuesday, November 15, 2022
Equity, Rockefeller Center, Technology, Health, Taunusturm, Spring, Project Destination, Global Vision, Student, Partnership, Industry, School, Multimedia, Entrepreneurship, Business development, Inclusion, ZO, Management, Mission Rock, Studio

NEW YORK, Nov. 15, 2022 /PRNewswire/ -- Tishman Speyer today announced an agreement to serve as the first-ever Global Partner with Project Destined, a social impact platform that provides students in underserved communities with training in financial literacy, entrepreneurship and real estate. 

Key Points: 
  • Tishman Speyer's leading executives in each market will offer local students the opportunity to explore the wide range of exciting careers available to them in the real estate industry.
  • Students in each city will form teams and be tasked with evaluating actual commercial real estate transactions.
  • This inaugural "Tishman Speyer Cup" will be judged by CEO Rob Speyer and other leading executives of the firm.
  • "We are extremely proud to launch our first global partnership with Tishman Speyer," said Cedric Bobo, Project Destined Co-Founder.

TISHMAN SPEYER EARNS SIX 5-STAR RATINGS FROM THE GLOBAL REAL ESTATE SUSTAINABILITY BENCHMARK (GRESB)

Retrieved on: 
Friday, October 21, 2022
Benchmark, Biophysical environment, ZO, ESG, Sustainability, Siemens Building Technologies, Investment, Senior, Goal, Taunusturm, Health, Spring, Rockefeller Center, USD, Renewable energy, Bank, Studio, Social, Mission Rock

NEW YORK, Oct. 21, 2022 /PRNewswire/ -- Tishman Speyer today announced that six of its submissions to the Global Real Estate Sustainability Benchmark (GRESB) earned the organization's coveted 5-Star ratings for 2022. 

Key Points: 
  • NEW YORK, Oct. 21, 2022 /PRNewswire/ -- Tishman Speyer today announced that six of its submissions to the Global Real Estate Sustainability Benchmark (GRESB) earned the organization's coveted 5-Star ratings for 2022.
  • With six U.S. and European Tishman Speyer portfolios ranked in the top 20 percent of this year's GRESB benchmark and receiving 5-star ratings, this represents Tishman Speyer's most successful year ever for GRESB ratings.
  • To learn more about Tishman Speyer's global commitment to environmental, social and governance, please click here for its newly-released ESG Report.
  • Tishman Speyer is a leading owner, developer, operator and investment manager of first-class real estate in 33 key markets across the United States, Europe, Asia and Latin America.

BeautyHealth’s Hydrafacial Announces Partnership to Develop Breakthrough Exosome Booster

Retrieved on: 
Wednesday, September 14, 2022
Vitamins, Supplements, Fashion, Women, Cosmetics, Other Health, Seniors, Generation X, Retail, Baby Boomers, Men, Catalog, Bridal, Luxury, Consumer, Department Stores, Biotechnology, Alternative Medicine, Health, Regenerative medicine, Health, Inflammation, Therapy, Time, Degenerative disease, Cytokine, COVID-19, Exosome, Ageing, Jennifer Lopez, Beauty, CGMP, Chemokine, Hyaluronic acid, Wound healing, OTCQB, Growth, Partnership, Hydradermabrasion, Regeneration, Murad, Technology, Protein, Solution, Private Securities Litigation Reform Act, Science, NASDAQ, ZO, Skin, SKIN, Vaccine, Pharmaceutical industry, Cosmetics

The booster will leverage novel exosome technology based on regenerative medical therapies and, once developed, will be available as a customized treatment addition for Hydrafacial.

Key Points: 
  • The booster will leverage novel exosome technology based on regenerative medical therapies and, once developed, will be available as a customized treatment addition for Hydrafacial.
  • We are excited to begin development with Organicell to co-create a potentially skin-changing Hydrafacial booster based on their breakthrough exosome technology, said BeautyHealth President and Chief Executive Officer Andrew Stanleick.
  • These benefits will help treat the skin and address signs of aging when delivered as a booster through Hydrafacials exceptional delivery system.
  • Hydrafacials co-creation model can deliver a booster in under six months, a fraction of the time typically required to develop a full skincare line.

Liliana Marcu Awan, MD, FAAFP, AAFP is recognized by Continental Who's Who

Retrieved on: 
Friday, February 18, 2022
Substance Abuse and Mental Health Services Administration, Patient, Lists of diseases, Family, Temple University, Depression, Addiction psychiatry, AAFP, Parent, Jose B. Lingad Memorial Regional Hospital, American Academy of Family Physicians, Family medicine, Transitive dependency, Tic disorder, Substance Abuse, Lima Memorial Health System, Dominican Republic, UNIBE, Anxiety, University of Mississippi Medical Center, Ownership, Medical Center, IV, University, AAAP, Romanian Orthodox Church, SAMHSA, MD, Skin care, Orthodox Church, PTSD, American Academy of Addiction Psychiatry, American Academy, Multimedia, Continental, OCD, FAAFP, Ketamine, Suicidal ideation, Alternative medicine degrees, Addiction medicine, ZO, Hospital, Pharmaceutical industry, Medicine, Medicine, Biology, New Vision (newspaper), Psychiatry, Zain

HOLLYWOOD, Fla., Feb. 17, 2022 /PRNewswire/ -- Liliana Marcu Awan, MD, FAAFP, AAFP, is being recognized by Continental Who's Who as a Distinguished Family Physician for her outstanding contributions in the field of Medicine.

Key Points: 
  • HOLLYWOOD, Fla., Feb. 17, 2022 /PRNewswire/ -- Liliana Marcu Awan, MD, FAAFP, AAFP, is being recognized by Continental Who's Who as a Distinguished Family Physician for her outstanding contributions in the field of Medicine.
  • Currently, she serves as the Owner and Family Practitioner at the Medical Center of Hollywood Family, Cosmetic, and Ketamine Infusion Center.
  • Dr. Awan offers cosmetic procedures such as Botox, microdermabrasion, microneedling, radiofrequency, contouring, skin tightening, age spot removal, and ZO skin care.
  • Dr. Awan dedicates this recognition to her parents, Radu and Floare Marcu, and her children Rizvan, Saf, Zain, and Alina.